HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysisM. Juliana McElrath, Danilo R. Casimiro, Donald K. Carter et al.|The Lancet|2008Cited by 699
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like ParticlesPaul Goepfert, Harriet L. Robinson, Marnie Elizaga et al.|The Journal of Infectious Diseases|2011Cited by 177
A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)Gavin Churchyard, Cecilia Morgan, Elizabeth M. Adams et al.|PLoS ONE|2011Cited by 137
Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical TrialBeryl A. Koblin, Martín Casapía, Cecilia Morgan et al.|PLoS ONE|2011Cited by 43
Timing of Plasmid Cytokine (IL-2/Ig) Administration Affects HIV-1 Vaccine Immunogenicity in HIV-Seronegative SubjectsLindsey R. Baden, William A. Blattner, Cecilia Morgan et al.|The Journal of Infectious Diseases|2011Cited by 25